Published in Cancer Radiother on August 23, 2006
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene (2006) 4.85
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol (1997) 3.60
Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol (1996) 2.53
Histoprognostic grade in BRCA1-associated breast cancer. Lancet (1995) 2.47
WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene (2001) 2.32
Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol (2001) 2.29
Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer (1989) 2.18
Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet (2000) 2.15
High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Am J Trop Med Hyg (1994) 2.05
Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer (1995) 2.05
Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. J Biol Chem (2000) 1.99
Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst (1980) 1.93
Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications. Breast Cancer Res Treat (2010) 1.77
[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]. Bull Cancer (1991) 1.63
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
Medullary carcinoma of the breast. A multicenter study of its diagnostic consistency. Arch Pathol Lab Med (1993) 1.57
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer (2000) 1.50
Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. Int J Neurosci (1996) 1.45
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene (2008) 1.44
Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res (1998) 1.39
Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene (1999) 1.39
Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantation. Bone Marrow Transplant (1995) 1.38
FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer (1993) 1.37
Vaginal extraction of pelvic masses following operative laparoscopy. Surg Endosc (2002) 1.37
Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol (1990) 1.34
Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res (1997) 1.33
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer (2003) 1.31
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res (2000) 1.29
Recurrent lesions in human Leishmania braziliensis infection--reactivation or reinfection? Lancet (1990) 1.27
Prolonged apnea and cardiac arrhythmias in infants discharged from neonatal intensive care units: failure to predict an increased risk for sudden infant death syndrome. Pediatrics (1982) 1.27
Changes in respiratory pattern resulting from the use of a facemask to record respiration in newborn infants. Pediatr Res (1982) 1.26
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch (1999) 1.24
Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study. Histopathology (2003) 1.23
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene (2006) 1.23
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res (1996) 1.21
Helium-neon laser treatment transforms fibroblasts into myofibroblasts. Am J Pathol (1990) 1.21
Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol (2004) 1.19
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study. Virchows Arch (2004) 1.19
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006) 1.15
Determinants of patients' choice of reconstruction with mastectomy for primary breast cancer. Ann Surg Oncol (2004) 1.15
Massage therapy reduces anxiety and enhances EEG pattern of alertness and math computations. Int J Neurosci (1996) 1.13
Didelphis marsupialis, an important reservoir of Trypanosoma (Schizotrypanum) cruzi and Leishmania (Leishmania) chagasi in Colombia. Am J Trop Med Hyg (1994) 1.13
The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys (1990) 1.12
Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer (1990) 1.07
Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer (1989) 1.07
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. Br J Cancer (2010) 1.05
Breast-conserving therapy for macroscopically multiple cancers. Ann Surg (1990) 1.04
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol (1998) 1.04
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines. Oncogene (2007) 1.04
Pattern of polyomavirus replication from infection until tumor formation in the organs of athymic nu/nu mice. J Virol (1990) 1.03
Cooling dissociates glucose-induced insulin release from electrical activity and cation fluxes in rodent pancreatic islets. J Physiol (1984) 1.03
Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol (2006) 1.03
Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosomes Cancer (1995) 1.01
Incisional hernia in gynecologic oncology patients: a 10-year study. Obstet Gynecol (2001) 1.00
Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study. Hum Pathol (1986) 0.99
Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys (2000) 0.98
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. Br J Cancer (2007) 0.98
Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation. J Pathol (1994) 0.97
A seven-gene prognostic model for platinum-treated ovarian carcinomas. Br J Cancer (2011) 0.96
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial). Br J Cancer (1999) 0.96
A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol (2008) 0.94
Novel indications for BRCA1 screening using individual clinical and morphological features. Int J Cancer (1999) 0.93
A multicentre collaborative study on the use of cold scalpel and electrocautery for midline abdominal incision. Am J Surg (2001) 0.93
Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors. Cancer Chemother Pharmacol (1979) 0.92
[Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications]. Cancer Radiother (2010) 0.92
VEGFc and VEGFR3 expression in human thyroid pathologies. Int J Cancer (2000) 0.91
Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol (1999) 0.91
Is breast conservation after local recurrence feasible? Eur J Cancer (1991) 0.91
Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys (1998) 0.90
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol (2001) 0.90
Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene (1997) 0.90
Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study. Ann Oncol (2014) 0.88
Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas. Cancer Res (1986) 0.88
[Cavitating nodules in a 40-year-old non-smoking woman: a very particular tumour]. Rev Mal Respir (2012) 0.88
Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol (2004) 0.87
Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders. Am J Pathol (1988) 0.87
Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features. Cancer Chemother Pharmacol (1979) 0.87
ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer (1995) 0.87
Inflammatory carcinoma of the breast. Eur J Gynaecol Oncol (1992) 0.87
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment. Bone Marrow Transplant (2004) 0.87
Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line. Int J Oncol (2000) 0.86
Robot-assisted laparoscopy in gynecologic oncology. Surg Endosc (2008) 0.86
High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome. Bone Marrow Transplant (1998) 0.84
Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas. J Pathol (1997) 0.84
Histological differentiation in human breast cancer is related to steroid receptors and stromal elastosis. Cancer Chemother Pharmacol (1980) 0.84
Port site metastasis after laparoscopy for uterine cervical carcinoma. Surg Endosc (2003) 0.83
Two-stage hepatectomy: who will not jump over the second hurdle? Eur J Surg Oncol (2012) 0.83
High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study. Anticancer Res (2005) 0.83
[Expected impact of a quadrivalent HPV vaccine in France]. J Gynecol Obstet Biol Reprod (Paris) (2009) 0.83
Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma. Oncogene (1995) 0.82
Does a better grade of tumour occurring in women under hormone replacement therapy compensate for their lower probability of detection by screening mammography. J Med Screen (2002) 0.82
Rectus abdominis myocutaneous flap in radical oncopelvic surgery: a safe and useful procedure. Eur J Surg Oncol (2005) 0.82
Example of a chaotic crystal: the labyrinth. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.82